Malignant peritoneal mesothelioma

Vincenzo de Pangher Manzini1

  • 1Azienda per i Servizi Sanitari 2 Isontina, Ospedali di Monfalcone e Gorizia, Unità Operativa Complessa di Oncologia, Monfalcone, GO, Italy. oncologiamn@ass2.sanita.fvg.it

Tumori
|April 27, 2005
PubMed
Abstract

Insights

Malignant peritoneal mesothelioma is a rare cancer with challenging diagnosis and rapid progression. This study introduces a new classification system to aid in early detection and management of this aggressive disease.

Area of Science:

  • Oncology
  • Pathology
  • Medical Diagnostics

Background:

  • Malignant peritoneal mesothelioma is an uncommon malignancy with poorly understood clinical features.
  • The disease presents variably, making diagnosis difficult and often delayed.

Purpose of the Study:

  • To elucidate the clinical characteristics of malignant peritoneal mesothelioma.
  • To investigate diagnostic methods, treatment responses, and survival outcomes.
  • To propose a novel clinical classification for improved diagnosis.

Main Methods:

  • Retrospective analysis of 15 patients diagnosed with malignant peritoneal mesothelioma.
  • Evaluation of asbestos exposure, clinical presentation, laboratory findings (thrombocytosis), imaging, peritoneal fluid cytology, and surgical interventions.
  • Analysis of diagnosis time, treatment efficacy, and survival duration.

Main Results:

  • Asbestos exposure was noted in 12 male patients.
  • Common symptoms included abdominal pain, ascites, mass, weight loss, and fever; 5 cases presented as surgical emergencies.
  • Thrombocytosis was present in 11 patients; cytology confirmed malignancy in 8/10 cases. A new classification (classical, surgical, medical) was proposed. Mean diagnosis time was 122 days, and mean survival was 345 days.

Conclusions:

  • Malignant peritoneal mesothelioma is characterized by diagnostic difficulty, rapid progression, poor therapeutic response, and high thrombocytosis prevalence.
  • A new clinical classification (classical, surgical, medical) may enhance diagnostic accuracy.
  • Early diagnosis of malignant peritoneal mesothelioma remains a critical unmet need.